Literature DB >> 8026884

Prognostic value of deoxyribonucleic acid content in prostate cancer: a review of current results.

J Adolfsson1.   

Abstract

A total of 115 articles on prostate cancer were reviewed for data on the prognostic value of DNA content in the tumor cells. In 44 series, data pertinent to this review were found. There was no consensus in the literature with respect to methods of analysis of DNA content or definitions of subclasses of DNA content such as categories of ploidy. The DNA content of prostate cancer cells was strongly related to tumor grade and stage. When analyzed as a single parameter in univariate analyses, the DNA content had a prognostic value with respect to overall or disease-specific survival. In multivariate analyses the additional prognostic value of the DNA content was less convincing when analysed with tumor grade and stage. The prognostic data from univariate and multivariate analyses available in the literature were mainly derived from patients with advanced disease and data on localized, potentially curable disease were scanty and conflicting.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026884     DOI: 10.1002/ijc.2910580212

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer.

Authors:  Margaret A Leversha; Jialian Han; Zahra Asgari; Daniel C Danila; Oscar Lin; Rita Gonzalez-Espinoza; Aseem Anand; Hans Lilja; Glenn Heller; Martin Fleisher; Howard I Scher
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

2.  A non-diploid DNA status is linked to poor prognosis in renal cell cancer.

Authors:  Franziska Büscheck; Christoph Fraune; Martina Kluth; Maximilian Lennartz; Ronald Simon; Claudia Hube-Magg; Christian Morlock; Silvano Barbieri; Carolin Wahl; Christian Eichelberg; Christina Möller-Koop; Doris Höflmayer; Corinna Wittmer; Waldemar Wilczak; Guido Sauter; Margit Fisch; Till Eichenauer; Michael Rink
Journal:  World J Urol       Date:  2020-05-02       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.